Ionically bridged dexamethasone sodium phosphate-zinc-PLGA nanocomplex in alginate microgel for the local treatment of ulcerative colitis
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q1Scopus Q1KCI Q1
- 저널
- Archives of Pharmacal Research46(7) · pp.646 · 2023
- 피인용
- Web of Science 10Scopus 10KCI 1
- FWCI (Scopus)
- 0.78
- JCR IF
- JCR 2022 6.7
- ISSN
- 0253-6269
저자
- 사파르바예바 아루잔제1저자Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 이주호Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 쉐이 퓨 랑이Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 김지현Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 곽동민Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 김현우Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- Lee, Eun HeeKorea Univ, Coll Pharm, Sejong 30019, South Korea
- 황성환Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 김민수Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 문형룡Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 정연진Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
- 유진욱교신저자Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
초록
Colon-targeted oral drug delivery systems comprising nanoparticles and microparticles have emerged as promising tools for the treatment of ulcerative colitis (UC) because they minimize side effects and maximize the local drug concentration. Dexamethasone sodium phosphate (DSP) is a potent anti-inflammatory glucocorticoid used for the treatment of UC. However, it remains a rather short-term treatment option owing to its side effects. In the present study, we developed the alginate gel encapsulating ionically bridged DSP-zinc-poly(lactic-co-glycolic acid) (PLGA) nanocomplex (DZP-NCs-in-microgel) for the oral local treatment of UC. The successful encapsulation of DSP-zinc-PLGA nanocomplex (DZP-NCs) in alginate microgel was confirmed by SEM imaging. The prepared gel released DZP-NCs in the stimulated intestinal fluid and dampened the release of DSP in the upper gastrointestinal tract. Furthermore, DZP-NCs-in-microgel alleviated colonic inflammation in a mouse model of dextran sodium sulfate-induced colitis by relieving clinical symptoms and histological marks. Our results suggest a novel approach for the oral colon-targeted delivery of dexamethasone sodium phosphate for the treatment of UC.
키워드
Ulcerative colitisDexamethasoneNanoparticlesDrug deliveryDELIVERYNANOPARTICLESENCAPSULATIONMODERATETHERAPYRELEASECALCIUM
식별자
- Scopus EID
- 2-s2.0-85166663767
- WoS UID
- 001041987700001
- KCI
- ART002986290



로그인
연구물 목록으로